Clinical Trials Directory

Trials / Conditions / Meningococcal Immunisation

Meningococcal Immunisation

7 registered clinical trials studyying Meningococcal Immunisation.

StatusTrialSponsorPhase
CompletedStudy on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers
NCT06284915
Sanofi Pasteur, a Sanofi CompanyPhase 3
CompletedStudy of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents
NCT06128733
Sanofi Pasteur, a Sanofi CompanyPhase 1 / Phase 2
CompletedStudy of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless
NCT05929651
Sanofi Pasteur, a Sanofi CompanyPhase 4
CompletedStudy of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatr
NCT05794230
Sanofi Pasteur, a Sanofi CompanyPhase 3
Active Not RecruitingStudy on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administe
NCT04936685
Sanofi Pasteur, a Sanofi CompanyPhase 3
TerminatedStudy of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines
NCT04825223
Sanofi Pasteur, a Sanofi CompanyPhase 1
CompletedStudy on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococca
NCT04490018
Sanofi Pasteur, a Sanofi CompanyPhase 3